Cost-Effectiveness of Rivaroxaban Compared with Enoxaparin for the Prevention of Venous Thromboembolism in Adult Patients Undergoing Elective Hip or Knee Replacement Surgery in Portugal
Foi desenvolvido um modelo de custo-efetividade que compara os custos e consequências associados a rivaroxabano relativamente a enoxaparina na prevenção do tromboembolismo venoso em doentes adultos submetidos a artoplastia eletiva da anca ou joelho. Esta análise foi desenvolvida na perspectiva da so...
Saved in:
Main Authors: | José Roxo Neves (Author), Kerstin Folkerts (Author), Sofia Umbelino (Author), Isabel Fonseca Santos (Author) |
---|---|
Format: | Book |
Published: |
Formifarma, LDA.,
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COST- EFFECTIVENESS ANALYSIS OF APIXABANO VS. ENOXAPARIN IN THE THROMBOEMBOLISM IN THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER ARTHROPLASTY ELECTIVE THE HIP OR KNEE
by: Óscar Lourenço, et al.
Published: (2012) -
Pharmacoeconomic study on rivaroxaban vs conventional venous thromboembolism prophylaxis following elective total hip or knee replacement surgery in Serbia: Single centre study
by: Perović Saša R., et al.
Published: (2017) -
Comparative safety and efficacy of antithrombotics in the management of venous thromboembolism after knee or hip replacement surgery: focus on rivaroxaban
by: Kwong LM
Published: (2013) -
Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service
by: Dalia M. Dawoud, et al.
Published: (2018) -
A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting
by: Zindel Sonja, et al.
Published: (2012)